The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Alekseev V.V.

Kafedra voenno-morskoĭ i gospital'noĭ khirurgii Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Flupirtin (katadolon): a nonstandard action on pain transmission

Authors:

Alekseev V.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(4): 101‑104

Read: 6187 times

Download PDF (RU)
Contact the author
Table of contents

FLUPIRTIN (KATADOLON): A NONSTANDARD ACTION ON PAIN TRANSMISSION
FLUPIRTIN (KATADOLON): A NONSTANDARD ACTION ON PAIN TRANSMISSION

To cite this article:

Alekseev VV. Flupirtin (katadolon): a nonstandard action on pain transmission. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(4):101‑104. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pote­ntial of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87
Myoadaptive overload syndromes of lower extremities in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):89-93
Current state of algo­logy — pain medi­cine — in the Russian Fede­ration. Burdenko's Journal of Neurosurgery. 2024;(6):5-12
Functional uncoupling of pain neuromatrix unde­rling reha­bilitation of patients with chro­nic pain. Russian Journal of Pain. 2024;(4):81-85
Comparison of long-term outcomes of different methods of lapa­roscopic inguinal hernia repair (TAPP and TEP). Endo­scopic Surgery. 2024;(6):5-12
Treatment of acute postoperative pain and prevention of chro­nic postoperative pain syndrome. Piro­gov Russian Journal of Surgery. 2024;(12):81-86
Myofascial orofacial pain: clinical and pathogenetic mechanisms, possibilities of botu­linum therapy. Russian Journal of Pain. 2025;(2):12-23
Prevalence of chro­nic pain in adult popu­lation of the Russian Fede­ration: an all-Russian epidemiological study. Russian Journal of Pain. 2025;(2):54-62
Abstract:

Keywords:

pathophysiology of pain
chronic pain
muscle spasm
flupirtin

Authors:

Alekseev V.V.

Kafedra voenno-morskoĭ i gospital'noĭ khirurgii Voenno-meditsinskoĭ akademii im. S.M. Kirova, Sankt-Peterburg

Close metadata

References:

  1. Alekseev V.V., Rachin A.P., Podchufarova E.V. Flupirtin (katadolon) nestandartnyi podkhod k terapii boli. Consilium Medicum, prilozhenie k zhurnalu 2009; 2: 50-53.
  2. Gribova N.P. Primenenie preparata katadolon v lechenii bolevykh sindromov pri radikulomieloishemii. Bol' 2003; 1.
  3. Kamchatnov P.R., Asanov A.Yu. Sovremennye vozmozhnosti farmakoterapii bolevykh sindromov. Bol' 2005; 3: 54-58.
  4. Kamchatnov P.R., Batysheva T.T., Ganzhula P.A. i dr. Primenenie katadolona u bol'nykh so spondilogennoi dorsalgiei. Zhurn nevrol i psikhiat 2006; 106: 11: 46-48.
  5. Kukushkin M.L., Khitrov N.K. Obshchaya patologiya boli. M: Meditsina 2004; 144.
  6. Mikhailovich V.A., Ignatov Yu.D. Bolevoi sindrom. L: Meditsina 1990; 336.
  7. Naprienko M.V., Filatova E.G. Primenenie katadolona v lechenii abuzusnoi golovnoi boli. Zhurn nevrol i psikhiat 2006; 10; Informatsionnyi portal "Bol'", www. Paininfo.ru
  8. Naprienko M.V., Filatova E.G. Katadolon v lechenii khronicheskoi golovnoi boli napryazheniya. Lechenie nervnykh boleznei, Informatsionnyi portal "Bol'", www. Paininfo.ru
  9. Rachin A.P. Desyat' dokazatel'stv uspeshnogo primeneniya flupirtina (katadolona) pri bolyakh v nizhnei chasti spiny. Lechenie nervnykh boleznei 2007; 8: 2: 21: 35-39.
  10. Ushkalova E. Lechenie zabolevanii kostno-myshechnoi sistemy (ot diklofenaka k flupirtinu). Vrach 2005; 5: Informatsionnyi portal "Bol'", www. Paininfo.ru
  11. Erdes Sh., Galushko E., Zotkin E. i dr. Effektivnost' katadolona (flupirtina) u patsientov s bolyami v nizhnei chasti spiny. Vrach 2007; 5: Informatsionnyi portal "Bol'", www. Paininfo.ru
  12. Block F., Pergande G., Schwarz M. Flupirtine reduced funcional deficits and neuronal damage after global ischaemia in rats. Brain Res 1997; 754: 279-284.
  13. Dickenson A.H. Pharmacology of pain transmission and control.. Pain 1996 - an updated review. Ed. J.N. Campbell 1996; IASP Press: 113-121
  14. Engel J. Flupirtine - a new centrally acting analgesic with unique chemical structure, Postgrad Med J 1987; 63: Suppi 3: 15-17.
  15. Friedel N.A., Fitton A. Flupirtine. A review of its farmacological properties and therapeutic efficacy in pain states. Dmgs 1993; 45: 548-569.
  16. Komuber J. et al. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. J Neural Transm 1999; 106: 857-867.
  17. Muller W.E.G. et.al. Protection offlupirtine on p-amyloid-induced apoptisis in neuronal cells in vitro. J Neurochem 1997; 68: 2371-2377.
  18. Mueller-Schwefe G. Flupirtine in Acute and Chronic Pain Associated with Muscle Tenseness. Results of a Postmarketing Surveillance Study. Fortschr Med 2003; 121: 3-10.
  19. Osbome N.N et al. Protection of rabbit retina from ischemic injury by flupirtine. Invest Ophtalm 1996; 37: 274-280.
  20. Schuster G., Schwarz M. et al. Flupirtine: A review of its neuroprotective and behavioral properties. CNS Dmg Review 1998; 4: 149-164.
  21. Schwarz M., Block F., Pergande G. NMDA-mediated muscle reluxant action offlupirtine in rats. NeuroReport 1994; 5: 1981-1984.
  22. Schwarz M., Schmitt T., Pergande G., Block F. NMDA and a2-adrenergic mechanisms are involved in the depressant action offlupirtine on spinal reflex in rats. Eur J Pharmacol 1995; 276: 247-255.
  23. Szelenyi I. et al. Mode of antinociceptive action of flupirtine in the rat. Br J Pharmacol 1989; 97: 835-842.
  24. Szelenyi I. et al. Pharmacological profile of flupirtine, a novel centrally acting non-opioid analgesic drug. Agents and Actions 1991; 32: Suppl: 119-123.
  25. Van Tulder M. European Guidelines For the Management Of Acute Nonspecific Low Back Pain In Primary Care 2004.
  26. Verdugo R.J., Cea J.G., Campero M. et al. Textbook of Clinical Neurology 1999, Saunders Company, USA Chapter 20: 333-349.
  27. Willis W.D. Signal transduction mechanisms. Pain 1996 - an updated review. Ed J N Campbell 1996; IASP Press 527-531.
  28. Worz R. et al. Flupirtine in comparison with chlormezanone in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study. Fortschr Med 1996; 114: 35-36: 500-504.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.